CleanTech Vanadium Mining Corp. has engaged Mercator Geological Services to prepare an independent technical report on its Campbell-Crotser fluorspar project in Kentucky, following National Instrument 43-101 standards. The report will detail geology, mineralization, and historical exploration, with completion expected in Q4 2026. CleanTech is also collaborating with the Kentucky Geological Survey to assay archived drill cores for fluorspar and other critical minerals, aiming to verify historical data under modern protocols. This work supports CleanTech's efforts to advance the project in the Illinois-Kentucky Fluorspar District, a key U.S. source of critical minerals.
CleanTech Vanadium Mining Corp.'s fluorspar project update provides context for Basic Materials sector activity on Pluang. For readers following Basic Materials, here is Pluang's market snapshot as of Sep 18, 2026 23:41 WIB: of 34 priced US stocks, 6 rose and 27 fell. Notable movers include DOW at USD 28.54 with a 1-day change of -3.22% and 100% sell order activity, ASPN at USD 4.99 down 2.73% with 100% buy order activity, and LAC at USD 2.81 down 2.60% with 58% sell and 42% buy order activity.
Grayscale Bitcoin Mini Trust (BTC) rose about 5.8% following Bitcoin's rebound above $80,000, reflecting renewed investor interest after the U.S. Senate failed to advance the CLARITY Act. The trust offers exposure to Bitcoin without direct ownership ...
Duke Energy Corporation's stock is projected to rise about 8.26% to a price target of $127, down slightly from $133, reflecting confidence despite a recent price dip. The company expects a 4.42% increase in earnings per share to $1.89 and a 3.86% ris...
Xenon Pharmaceuticals halted new patient enrollment in its psychiatry clinical trials for the drug azetukalner after reports of neuropsychiatric side effects. This pause led to a sharp 27.6% drop in its stock price, marking its worst day since 2017. ...
Innate Pharma reported an EPS of -$0.24, beating analyst estimates of -$0.29, and revenue of $6.5 million, slightly above expectations. The company secured a strategic partnership with Sobi for its drug lacutamab, receiving a $75 million upfront paym...
VanEck introduced the VEEM ETF, which aims to outperform the MSCI Emerging Markets index by focusing on stocks with improving analyst sentiment rather than market cap weighting. This active strategy differs from traditional broad EM funds like VWO an...
